HIMS HERS HEALTH INC

NYSE: HIMS (Hims & Hers Health, Inc.)

最近更新时间: 4天之前, 4:08AM

36.98

0.93 (2.58%)

前收盘价格 36.05
收盘价格 35.43
成交量 31,350,958
平均成交量 (3个月) 28,511,955
市值 8,206,728,704
市盈率 (P/E TTM) 69.77
预期市盈率 (P/E Forward) 56.18
价格/销量 (P/S) 4.14
股市价格/股市净资产 (P/B) 14.13
52周波幅
19.29 (-47%) — 72.98 (97%)
利润日期 3 Nov 2025
营业毛利率 9.21%
营业利益率 (TTM) 10.12%
稀释每股收益 (EPS TTM) 0.680
季度收入增长率 (YOY) 110.70%
季度盈利增长率 (YOY) 344.70%
总债务/股东权益 (D/E MRQ) 11.54%
流动比率 (MRQ) 1.59
营业现金流 (OCF TTM) 334.34 M
杠杆自由现金流 (LFCF TTM) 213.45 M
资产报酬率 (ROA TTM) 10.76%
股东权益报酬率 (ROE TTM) 36.79%

市场趋势

短期 中期
行业 Household & Personal Products (US) 看跌 看跌
Household & Personal Products (全球的) 看跌 看跌
股票 Hims & Hers Health, Inc. 看涨 看涨

AIStockmoo 评分

0.8
分析师共识 1.5
内部交易活动 NA
价格波动 2.0
技术平均移动指标 0.0
技术振荡指标 -0.5
平均 0.75

相关股票

股票 市值 DY P/E(TTM) P/B
HIMS 8 B - 69.77 14.13
ELF 5 B - 55.69 3.85
UL 149 B 1.55% 23.52 7.04
PG 347 B 0.68% 21.65 6.57
CL 64 B 0.63% 22.23 73.50
KMB 34 B 4.82% 17.54 25.91

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.

部门 Consumer Defensive
行业 Household & Personal Products
投资方式 Small Growth
内部持股比例 11.13%
机构持股比例 82.47%

所有权

姓名 日期 持有股份
Farallon Capital Management Llc 30 Sep 2025 10,746,852
52周波幅
19.29 (-47%) — 72.98 (97%)
目标价格波幅
32.00 (-13%) — 85.00 (129%)
85.00 (BTIG, 129.85%) 购买
68.00 (83.88%)
32.00 (B of A Securities, -13.47%) 卖出
平均值 61.67 (66.77%)
总计 2 购买, 1 卖出
平均价格@调整类型 47.03
公司 日期 目标价格 调整类型 价格@调整类型
B of A Securities 04 Nov 2025 32.00 (-13.47%) 卖出 42.79
BTIG 04 Nov 2025 85.00 (129.85%) 购买 42.79
Canaccord Genuity 12 Sep 2025 68.00 (83.88%) 购买 55.50

该时间范围内无数据。

日期 类型 细节
18 Nov 2025 CNBC Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq
13 Nov 2025 公告 Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys
03 Nov 2025 公告 Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results
02 Nov 2025 CNBC Where the blockbuster weight loss drug market stands today — and what’s coming next
17 Oct 2025 CNBC Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s
15 Oct 2025 公告 Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026
13 Oct 2025 公告 Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025
09 Oct 2025 公告 Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office
10 Sep 2025 公告 Hims Launches New Category in Men’s Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments
26 Aug 2025 TheFinance 4 Attractive US Growth Stocks Set to Sizzle Up Your Investment Portfolio
25 Aug 2025 公告 SueWallSt Podcast Explains Class Action Against Hims & Hers Health, Inc. (HIMS)
22 Aug 2025 公告 Tune Into the SueWallSt Podcast: Hims & Hers Health, Inc. (HIMS) Lawsuit Explained
21 Aug 2025 公告 Investors SueWallSt as Hims & Hers Health, Inc. Faces Securities Fraud Allegations
21 Aug 2025 公告 Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
20 Aug 2025 公告 Tune Into the SueWallSt Podcast: Hims & Hers Health, Inc. (HIMS) Lawsuit Explained
19 Aug 2025 公告 SueWallSt Podcast Explains Class Action Against Hims & Hers Health, Inc. (HIMS)
19 Aug 2025 公告 Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票